Estimaciones de analistas de Wall Street para Alterity Therapeutics Limited (ATHE): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Ratios de valoración
| Precio / Valor contable | 2.73 |
| EV / EBITDA | -3.58 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $132396 | $201174 | $108538 | 0 | $4.3M | $5.1M | $3.9M | $4.0M | $5.4M | 0 |
| Coste de Ventas | $21328 | $21799 | $29696 | $112427 | $360026 | $364665 | $285067 | $214304 | $127523 | $113010 |
| Beneficio Bruto | $111068 | $179375 | $78842 | -$112427 | $4.0M | $4.8M | $3.6M | $3.8M | $5.3M | -$113010 |
| I+D | $5.7M | $6.7M | $13.0M | $10.1M | $12.3M | $14.7M | $13.2M | $18.6M | $14.4M | $17.2M |
| Generales y Administrativos | $3.9M | $4.3M | $4.3M | $3.3M | $6.9M | $5.5M | $5.0M | $4.8M | $5.5M | $10.4M |
| Gastos Operativos | $6.8M | $11.1M | $12.5M | $10.1M | $19.2M | $20.3M | $18.2M | $23.4M | $19.9M | $27.7M |
| Beneficio Operativo | -$6.9M | -$7.8M | -$12.7M | -$10.4M | -$15.2M | -$15.5M | -$14.6M | -$19.6M | -$14.6M | -$27.8M |
| EBITDA | -$6.9M | -$11.4M | -$12.8M | -$13.3M | -$15.2M | -$17.4M | -$14.6M | -$19.6M | -$14.6M | -$27.7M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$7.5M | -$8.3M | -$12.3M | -$10.1M | -$15.3M | -$12.8M | -$13.7M | -$19.1M | -$12.1M | -$26.3M |
| Impuestos | $660213 | -$495440 | -$376031 | -$362188 | -$3.1M | $70008 | $104459 | $46088 | $68055 | -$3.4M |
| Beneficio Neto | -$7.5M | -$8.3M | -$12.0M | -$10.1M | -$15.3M | -$12.8M | -$13.8M | -$19.1M | -$12.1M | -$22.9M |
| BPA | $-8.46 | $-9.30 | $-11.64 | $-6.48 | $-5.40 | $-3.18 | $-3.42 | $-3.12 | $-1.14 | $-1.32 |
| BPA Diluido | $-8.46 | $-9.30 | $-11.64 | $-6.48 | $-5.40 | $-3.18 | $-3.42 | $-3.12 | $-1.14 | $-1.32 |
| Acciones en Circulación (Diluidas) | $889819 | $889819 | $1.0M | $1.5M | $2.8M | $4.0M | $4.0M | $6.1M | $10.7M | $17.5M |
Precio
| Precio | $3.85 |
| Capitalización | $65M |
| Bolsa | NASDAQ |
| País | AU |
Empresas relacionadas: ANVS · BTAI · DYAI · EVAX · GBIO · IGC · LIMN
Explorar sector: Healthcare · Biotechnology
Más secciones de ATHE: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones